Skip to main content

18F-FDG PET in Epilepsy

  • Chapter
  • First Online:
PET/CT in Brain Disorders

Abstract

This chapter will summarize the evidence supporting the clinical use of FDG-PET brain imaging in the evaluation of patients with pharmaco-resistant epilepsy considered for surgical treatment. We will discuss the clinical indications, the main patterns of hypometabolism observed, and the main advantages and limitations associated with its use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Scheffer IE, Berkovic S, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–21.

    PubMed  PubMed Central  Google Scholar 

  2. Gschwind M, Seeck M. Modern management of seizures and epilepsy. Swiss Med Wkly. 2016;146:w14310.

    PubMed  Google Scholar 

  3. Kwan P, Arzimanoglou A, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–77.

    CAS  PubMed  Google Scholar 

  4. de Tisi J, Bell GS, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011;378(9800):1388–95.

    PubMed  Google Scholar 

  5. Duncan JS. Imaging in the surgical treatment of epilepsy. Nat Rev Neurol. 2010;6(10):537–50.

    PubMed  Google Scholar 

  6. Mouthaan BE, Rados M, et al. Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe. Epilepsia. 2016;57(5):770–6.

    PubMed  Google Scholar 

  7. ILAE. ILAE Neuroimaging Commission recommendations for neuroimaging of patients with epilepsy. Epilepsia. 2005;38(s10):1–2.

    Google Scholar 

  8. Lascano AM, Perneger T, et al. Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates. Clin Neurophysiol. 2016;127(1):150–5.

    PubMed  Google Scholar 

  9. Von Oertzen J, Urbach H, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73(6):643–7.

    Google Scholar 

  10. Kumar A, Chugani HT. The role of radionuclide imaging in epilepsy, Part 1: Sporadic temporal and extratemporal lobe epilepsy. J Nucl Med. 2013a;54(10):1775–81.

    CAS  PubMed  Google Scholar 

  11. Kumar A, Chugani HT. The role of radionuclide imaging in epilepsy, Part 2: Epilepsy syndromes. J Nucl Med. 2013b;54(11):1924–30.

    PubMed  Google Scholar 

  12. Chassoux F, Rodrigo S, et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology. 2010;75(24):2168–75.

    CAS  PubMed  Google Scholar 

  13. Carne RP, O’Brien TJ, et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain. 2004;127.(Pt 10:2276–85.

    CAS  PubMed  Google Scholar 

  14. Li LM, Cendes F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain. 1999;122. (Pt 5:799–805.

    PubMed  Google Scholar 

  15. la Fougere C, Rominger A, et al. PET and SPECT in epilepsy: a critical review. Epilepsy Behav. 2009;15(1):50–5.

    PubMed  Google Scholar 

  16. Wieser HG. The role of PET in the diagnosis of epilepsies. Epileptologie. 2004;21:109–16.

    Google Scholar 

  17. Guedj E, Bonini F, et al. 18FDG-PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value. Epilepsia. 2015;56(3):414–21.

    CAS  PubMed  Google Scholar 

  18. Juhasz C, Nagy F, et al. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology. 1999;53(9):2037–45.

    CAS  PubMed  Google Scholar 

  19. Semah F. PET imaging in epilepsy: basal ganglia and thalamic involvement. Epileptic Disord. 2002;4(Suppl 3):S55–60.

    PubMed  Google Scholar 

  20. Chang CP, Yen DJ, et al. Unilateral thalamic hypometabolism in patients with temporal lobe epilepsy. J Formos Med Assoc. 2008;107(7):567–71.

    PubMed  Google Scholar 

  21. Kim YK, Lee DS, et al. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002;43(9):1167–74.

    PubMed  Google Scholar 

  22. Wang K, Liu T, et al. Comparative study of voxel-based epileptic foci localization accuracy between statistical parametric mapping and three-dimensional stereotactic surface projection. Front Neurol. 2016;7:164.

    PubMed  PubMed Central  Google Scholar 

  23. Mendes Coelho VC, Morita ME, et al. Automated online quantification method for (18)F-FDG positron emission tomography/CT improves detection of the epileptogenic zone in patients with pharmacoresistant epilepsy. Front Neurol. 2017;8:453.

    PubMed  PubMed Central  Google Scholar 

  24. Savic I, Altshuler L, et al. Localized cerebellar hypometabolism in patients with complex partial seizures. Epilepsia. 1996;37(8):781–7.

    CAS  PubMed  Google Scholar 

  25. Conrad GR, Sinha P. FDG PET imaging of subependymal gray matter heterotopia. Clin Nucl Med. 2005;30(1):35–6.

    PubMed  Google Scholar 

  26. Morioka T, Nishio S, et al. Functional imaging in periventricular nodular heterotopia with the use of FDG-PET and HMPAO-SPECT. Neurosurg Rev. 1999;22(1):41–4.

    CAS  PubMed  Google Scholar 

  27. Chugani HT, Conti JR. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol. 1996;11(1):44–8.

    CAS  PubMed  Google Scholar 

  28. Chandra PS, Salamon N, et al. FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia. 2006;47(9):1543–9.

    PubMed  Google Scholar 

  29. Chugani HT, Mazziotta JC, et al. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Ann Neurol. 1987;21(1):4–13.

    CAS  PubMed  Google Scholar 

  30. You SJ, Lee JK, et al. Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia. Brain and Development. 2007;29(3):167–70.

    PubMed  Google Scholar 

  31. Sarikaya I. PET studies in epilepsy. Am J Nucl Med Mol Imaging. 2015;5(5):416–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Chassoux F, Artiges E, et al. (18)F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy. Neurology. 2017;88(11):1045–53.

    CAS  PubMed  Google Scholar 

  33. Wong CH, Bleasel A, et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia. 2010;51(8):1365–73.

    PubMed  Google Scholar 

  34. Wong CH, Bleasel A, et al. Relationship between preoperative hypometabolism and surgical outcome in neocortical epilepsy surgery. Epilepsia. 2012;53(8):1333–40.

    PubMed  Google Scholar 

  35. Hinde S, Soares M, et al. The added clinical and economic value of diagnostic testing for epilepsy surgery. Epilepsy Res. 2014;108(4):775–81.

    PubMed  PubMed Central  Google Scholar 

  36. Desarnaud S, Mellerio C, et al. (18)F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI. Eur J Nucl Med Mol Imaging. 2018;45(8):1449–60.

    CAS  PubMed  Google Scholar 

  37. Salamon N, Kung J, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71(20):1594–601.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Hodolic M, Topakian R, et al. (18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy. Radiol Oncol. 2016;50(3):247–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Meltzer CC, Adelson PD, et al. Planned ictal FDG PET imaging for localization of extratemporal epileptic foci. Epilepsia. 2000;41(2):193–200.

    CAS  PubMed  Google Scholar 

  40. Garibotto V, Heinzer S, et al. Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med. 2013;38(1):e13–8.

    PubMed  Google Scholar 

  41. Grouiller F, Delattre BM, et al. All-in-one interictal presurgical imaging in patients with epilepsy: single-session EEG/PET/(f)MRI. Eur J Nucl Med Mol Imaging. 2015;42(7):1133–43.

    PubMed  Google Scholar 

  42. Paldino MJ, Yang E, et al. Comparison of the diagnostic accuracy of PET/MRI to PET/CT-acquired FDG brain exams for seizure focus detection: a prospective study. Pediatr Radiol. 2017;47(11):1500–7.

    PubMed  Google Scholar 

  43. Shin HW, Jewells V, et al. Initial experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy. Seizure. 2015;31:1–4.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mainta, I.C., Picard, F., Garibotto, V. (2019). 18F-FDG PET in Epilepsy. In: Fraioli, F. (eds) PET/CT in Brain Disorders. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-030-01523-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01523-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01522-0

  • Online ISBN: 978-3-030-01523-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics